elmiradaily.com
Allergan Inks $750 Million Settlement with Namenda Purchasers - Elmira Daily
Purchasers of Allerganp-’s Namenda asked a federal decide Tuesday to approve a $750 million settlement of allegations that the drugmaker conspired to keep generic versions of the Alzheimer’s medicine off the market. Lawyers for the plaintiffs stated the preliminary settlement, which requires a judge’s approval, would be the biggest amount paid by one defendant to …